Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Glenmark Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532296NSE Symbol: GLENMARKP/E(TTM):30.82
ISIN Demat:INE935A01035Div & Yield %:0.13EPS(TTM):61.81
Book Value(Rs):868.3164333Market Cap ( Cr.):53763.49Face Value(Rs):1
    Change Company 
(Rs In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
SOURCES OF FUNDS :      
Share Capital 28.2228.2228.2228.2228.2228.22
Reserves Total 22942.4017849.2516710.3714781.2913198.0511913.87
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds22970.6217877.4716738.5914809.5113226.2711942.09
Secured Loans 0.000.000.000.000.006.11
Unsecured Loans 707.293221.223737.703703.993573.763128.37
Total Debt707.293221.223737.703703.993573.763134.48
Other Liabilities131.94372.58121.32136.61205.6588.51
Total Liabilities23809.8521471.2720597.6118650.1117005.6815165.08
APPLICATION OF FUNDS :      
Gross Block 3392.753183.653026.282848.562595.062260.10
Less : Accumulated Depreciation 1636.501437.701273.951126.07983.11846.62
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 1756.251745.951752.331722.491611.951413.48
Lease Adjustment 0.000.000.000.000.000.00
Capital Work in Progress197.67172.34109.04131.40200.01286.20
Producing Properties0.000.000.000.000.000.00
Investments 12964.7910332.718559.396989.954713.933268.75
Current Assets, Loans & Advances      
Inventories 1142.691090.21951.66762.39837.50911.21
Sundry Debtors 2484.472505.662678.322488.751835.242087.13
Cash and Bank129.1593.7929.6315.7988.26256.48
Loans and Advances 925.17696.82743.311642.201662.891886.33
Total Current Assets4681.484386.484402.934909.124423.895141.15
Less : Current Liabilities and Provisions      
Current Liabilities 3249.792952.142168.391834.311827.481855.86
Provisions 354.74162.52148.49133.11118.45121.75
Total Current Liabilities3604.543114.662316.881967.411945.921977.62
Net Current Assets1076.941271.822086.052941.712477.973163.54
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets475.611160.251137.471118.721081.341063.23
Deferred Tax Liability309.77213.50214.20265.43276.60351.10
Net Deferred Tax165.84946.75923.27853.29804.74712.13
Other Assets7648.377001.707167.546011.277197.086320.98
Total Assets23809.8521471.2620597.6218650.1117005.6815165.08
Contingent Liabilities2658.493443.303325.063730.174430.593680.94